Cocores A, Smirnoff L, Greco G, Herrera R, Monteith T
Curr Pain Headache Rep. 2025; 29(1):47.
PMID: 39954214
PMC: 11829934.
DOI: 10.1007/s11916-024-01314-7.
MacNeil A, Taunque A, Leo S, Li G, de Groh M, Jiang Y
J Pain Res. 2024; 17:3845-3866.
PMID: 39583197
PMC: 11586004.
DOI: 10.2147/JPR.S469798.
Chen X, Gui W, Li H, Deng Z, Wang Y
Brain Behav. 2024; 14(2):e3427.
PMID: 38361322
PMC: 10869885.
DOI: 10.1002/brb3.3427.
de Lahoz M, Barjola P, Pelaez I, Ferrera D, Fernandes-Magalhaes R, Mercado F
Biomedicines. 2023; 11(11).
PMID: 38002030
PMC: 10669837.
DOI: 10.3390/biomedicines11113030.
Affatato O, Dahlen A, Rukh G, Schioth H, Mwinyi J
BMC Neurol. 2023; 23(1):284.
PMID: 37507671
PMC: 10375767.
DOI: 10.1186/s12883-023-03336-x.
Atopic Disorders and Their Risks of Migraine: A Nationwide Population-Based Cohort Study.
Han J, Lee H, Yook H, Han K, Lee J, Park Y
Allergy Asthma Immunol Res. 2023; 15(1):55-66.
PMID: 36693358
PMC: 9880296.
DOI: 10.4168/aair.2023.15.1.55.
The Microbiota-Dependent Treatment of Wuzhuyu Decoction for Chronic Migraine Model Rat Associated with Anxiety-Depression Like Behavior.
Nan N, Wang Q, Li M, Xu Y, Guo X, Xu R
Oxid Med Cell Longev. 2023; 2023:2302653.
PMID: 36647428
PMC: 9840058.
DOI: 10.1155/2023/2302653.
The not so hidden impact of interictal burden in migraine: A narrative review.
Vincent M, Viktrup L, Nicholson R, Ossipov M, Vargas B
Front Neurol. 2022; 13:1032103.
PMID: 36408525
PMC: 9669578.
DOI: 10.3389/fneur.2022.1032103.
Acupuncture Treatment is Associated with Reduced Dementia Risk in Patients with Migraine: A Propensity-Score-Matched Cohort Study of Real-World Data.
Huang C, Lin M, Chou I, Hsieh C
Neuropsychiatr Dis Treat. 2022; 18:1895-1906.
PMID: 36065385
PMC: 9440707.
DOI: 10.2147/NDT.S372076.
Identifying functional brain abnormalities in migraine and depression comorbidity.
Yang Y, Wei K, Zhang H, Hu H, Yan L, Gui W
Quant Imaging Med Surg. 2022; 12(4):2288-2302.
PMID: 35371950
PMC: 8923836.
DOI: 10.21037/qims-21-667.
Wen Dan Tang: A Potential Jing Fang Decoction for Headache Disorders?.
Pradhan S, Li Y, Gantenbein A, Angst F, Lehmann S, Shaban H
Medicines (Basel). 2022; 9(3).
PMID: 35323721
PMC: 8955743.
DOI: 10.3390/medicines9030022.
Migraine patients visiting Chinese medicine hospital: Protocol for a prospective, registry-based, real-world observational cohort study.
Lyu S, Zhang C, Zhang A, Sun J, Xue C, Guo X
PLoS One. 2022; 17(3):e0265137.
PMID: 35290411
PMC: 8923465.
DOI: 10.1371/journal.pone.0265137.
Association of Depression with Migraine without Aura; A Cross-Sectional Study.
Meshkat S, Moghanlou M, Tafakhori A, Salimi A, Aghamollaii V
Clin Neuropsychiatry. 2021; 16(4):182-186.
PMID: 34908954
PMC: 8650174.
Detecting Abnormal Neuronal Activity in a Chronic Migraine Model by Egr1-EGFP Transgenic Mice.
Wang F, Jiang W, Gao L, Liu C, Deng M, Ren X
Front Neurosci. 2021; 15:705938.
PMID: 34456674
PMC: 8387874.
DOI: 10.3389/fnins.2021.705938.
A narrative review of the importance of pharmacokinetics and drug-drug interactions of preventive therapies in migraine management.
Joshi S, Tepper S, Lucas S, Rasmussen S, Nelson R
Headache. 2021; 61(6):838-853.
PMID: 34214182
PMC: 8361687.
DOI: 10.1111/head.14135.
Migraine Is More Than Just Headache: Is the Link to Chronic Fatigue and Mood Disorders Simply Due to Shared Biological Systems?.
Karsan N, Goadsby P
Front Hum Neurosci. 2021; 15:646692.
PMID: 34149377
PMC: 8209296.
DOI: 10.3389/fnhum.2021.646692.
Neuroimmunology of depression.
Sarno E, Moeser A, Robison A
Adv Pharmacol. 2021; 91:259-292.
PMID: 34099111
PMC: 8877598.
DOI: 10.1016/bs.apha.2021.03.004.
Pathophysiological Bases of Comorbidity in Migraine.
Altamura C, Corbelli I, de Tommaso M, Di Lorenzo C, Di Lorenzo G, Di Renzo A
Front Hum Neurosci. 2021; 15:640574.
PMID: 33958992
PMC: 8093831.
DOI: 10.3389/fnhum.2021.640574.
Hypoechogenicity of the midbrain raphe detected by transcranial sonography: an imaging biomarker for depression in migraine patients.
Zhang Y, Liu Y, Han R, Liu K, Xing Y
Ther Adv Neurol Disord. 2021; 14:17562864211007708.
PMID: 33912243
PMC: 8047820.
DOI: 10.1177/17562864211007708.
High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis.
Affatato O, Moulin T, Pisanu C, Babasieva V, Russo M, Aydinlar E
J Transl Med. 2021; 19(1):133.
PMID: 33789668
PMC: 8011097.
DOI: 10.1186/s12967-021-02801-w.